Annals of the New York Academy of Sciences

Cover image for Vol. 1270 Thymosins in Health and Disease II

October 2012

Volume 1270 Thymosins in Health and Disease II

Pages vii–ix, 1–121

  1. Introduction

    1. Top of page
    2. Introduction
    3. Original Articles
    4. Corrigendum
    1. Introduction for Thymosins in Health and Disease (pages vii–ix)

      Allan L. Goldstein and Enrico Garaci

      Article first published online: 10 OCT 2012 | DOI: 10.1111/j.1749-6632.2012.06778.x

  2. Original Articles

    1. Top of page
    2. Introduction
    3. Original Articles
    4. Corrigendum
    1. Thymosin α1 in melanoma: from the clinical trial setting to the daily practice and beyond (pages 8–12)

      Riccardo Danielli, Ester Fonsatti, Luana Calabrò, Anna Maria Di Giacomo and Michele Maio

      Article first published online: 10 OCT 2012 | DOI: 10.1111/j.1749-6632.2012.06757.x

    2. Thymosin α1 as a stimulatory agent of innate cell-mediated immune response (pages 13–20)

      Annalucia Serafino, Pasquale Pierimarchi, Francesca Pica, Federica Andreola, Roberta Gaziano, Noemi Moroni, Manuela Zonfrillo, Paola Sinibaldi-Vallebona and Enrico Garaci

      Article first published online: 10 OCT 2012 | DOI: 10.1111/j.1749-6632.2012.06707.x

    3. Thymosin α1 continues to show promise as an enhancer for vaccine response (pages 21–27)

      Cynthia Tuthill, Israel Rios, Alfonso De Rosa and Roberto Camerini

      Article first published online: 10 OCT 2012 | DOI: 10.1111/j.1749-6632.2012.06680.x

    4. The use of angiogenic-antimicrobial agents in experimental wounds in animals: problems and solutions (pages 28–36)

      Paritosh Suman, Harikrishnan Ramachandran, Sossy Sahakian, Kamraan Z. Gill, Basil A. J. Horst, Shanta M. Modak and Mark A. Hardy

      Article first published online: 10 OCT 2012 | DOI: 10.1111/j.1749-6632.2012.06653.x

    5. The regenerative peptide thymosin β4 accelerates the rate of dermal healing in preclinical animal models and in patients (pages 37–44)

      Terry Treadwell, Hynda K. Kleinman, David Crockford, Mark A. Hardy, Giorgio T. Guarnera and Allan L. Goldstein

      Article first published online: 10 OCT 2012 | DOI: 10.1111/j.1749-6632.2012.06717.x

    6. Thymosin β4: a potential novel dry eye therapy (pages 45–50)

      Gabriel Sosne, Ping Qiu, George W. Ousler 3rd, Steven P. Dunn and David Crockford

      Article first published online: 10 OCT 2012 | DOI: 10.1111/j.1749-6632.2012.06682.x

    7. Neuroprotective and neurorestorative effects of thymosin β4 treatment following experimental traumatic brain injury (pages 51–58)

      Ye Xiong, Asim Mahmood, Yuling Meng, Yanlu Zhang, Zheng Gang Zhang, Daniel C. Morris and Michael Chopp

      Article first published online: 10 OCT 2012 | DOI: 10.1111/j.1749-6632.2012.06683.x

    8. Use of the cardioprotectants thymosin β4 and dexrazoxane during congenital heart surgery: proposal for a randomized, double-blind, clinical trial (pages 59–65)

      Daniel Stromberg, Tia Raymond, David Samuel, David Crockford, William Stigall, Steven Leonard, Eric Mendeloff and Andrew Gormley

      Article first published online: 10 OCT 2012 | DOI: 10.1111/j.1749-6632.2012.06710.x

    9. Cardiac repair with thymosin β4 and cardiac reprogramming factors (pages 66–72)

      Deepak Srivastava, Masaki Ieda, Jidong Fu and Li Qian

      Article first published online: 10 OCT 2012 | DOI: 10.1111/j.1749-6632.2012.06696.x

    10. NMR structural studies of thymosin α1 and β-thymosins (pages 73–78)

      David E. Volk, Cynthia W. Tuthill, Miguel-Angel Elizondo-Riojas and David G. Gorenstein

      Article first published online: 10 OCT 2012 | DOI: 10.1111/j.1749-6632.2012.06656.x

    11. The role of biologically active peptides in tissue repair using umbilical cord mesenchymal stem cells (pages 93–97)

      Carlos Cabrera, Gabriela Carriquiry, Chiara Pierinelli, Nancy Reinoso, Javier Arias-Stella and Javier Paino

      Article first published online: 10 OCT 2012 | DOI: 10.1111/j.1749-6632.2012.06727.x

    12. Thymosin β4 sustained release from poly(lactide-co-glycolide) microspheres: synthesis and implications for treatment of myocardial ischemia (pages 112–119)

      Jeffrey E. Thatcher, Tré Welch, Robert C. Eberhart, Zoltan A. Schelly and J. Michael DiMaio

      Article first published online: 10 OCT 2012 | DOI: 10.1111/j.1749-6632.2012.06681.x

  3. Corrigendum

    1. Top of page
    2. Introduction
    3. Original Articles
    4. Corrigendum
    1. You have free access to this content
      Corrigendum for Ann. N.Y. Acad. Sci. 2005. 1051: 779–786 (page 120)

      Article first published online: 10 OCT 2012 | DOI: 10.1111/j.1749-6632.2012.06792.x

      This article corrects:

      Response of Vasculitic Peripheral Neuropathy to Intravenous Immunoglobulin

      Vol. 1051, Issue 1, 779–786, Article first published online: 9 JAN 2006

    2. You have free access to this content
      Corrigendum for Ann. N.Y. Acad. Sci. 2012. 1254: 57–65 (page 121)

      Article first published online: 10 OCT 2012 | DOI: 10.1111/j.1749-6632.2012.06793.x

      This article corrects:

      A bird's-eye view of cell therapy and tissue engineering for cardiac regeneration

      Vol. 1254, Issue 1, 57–65, Article first published online: 30 APR 2012

SEARCH

SEARCH BY CITATION